- According to estimates from 6 analysts, Amphastar Pharmaceuticals, Inc. stock's average price target has fallen from $22.83 to $22, with forecasts ranging from $19 to $30 per share
- Based on the Jun. 26 closing price, the updated target implies approximately 1% potential upside
- Consensus rating remains at “Hold” across 7 covering analysts, with 0 Buys, 6 Holds and 1 Sells
Explore more price target data and ratings for Amphastar Pharmaceuticals, Inc. on the , and track all previous and future analyst recommendations for Amphastar Pharmaceuticals, Inc. in the dedicated .
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.